These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 22849533)

  • 21. Aripiprazole for the treatment of irritability associated with autism.
    Farmer CA; Aman MG
    Expert Opin Pharmacother; 2011 Mar; 12(4):635-40. PubMed ID: 21294670
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ECG parameters in children and adolescents treated with aripiprazole and risperidone.
    Germanò E; Italiano D; Lamberti M; Guerriero L; Privitera C; D'Amico G; Siracusano R; Ingrassia M; Spina E; Calabrò MP; Gagliano A
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jun; 51():23-7. PubMed ID: 24211841
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Yokukansan (TJ-54) for treatment of pervasive developmental disorder not otherwise specified and Asperger's disorder: a 12-week prospective, open-label study.
    Miyaoka T; Wake R; Furuya M; Liaury K; Ieda M; Kawakami K; Tsuchie K; Inagaki T; Horiguchi J
    BMC Psychiatry; 2012 Nov; 12():215. PubMed ID: 23194148
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety and tolerability of aripiprazole for irritability in pediatric patients with autistic disorder: a 52-week, open-label, multicenter study.
    Marcus RN; Owen R; Manos G; Mankoski R; Kamen L; McQuade RD; Carson WH; Findling RL
    J Clin Psychiatry; 2011 Sep; 72(9):1270-6. PubMed ID: 21813076
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Retrospective Naturalistic Study of Ziprasidone for Irritability in Youth with Autism Spectrum Disorder.
    Dominick K; Wink LK; McDougle CJ; Erickson CA
    J Child Adolesc Psychopharmacol; 2015 Jun; 25(5):397-401. PubMed ID: 26091194
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Second generation antipsychotics in Asperger's Disorder and high functioning autism: a systematic review of the literature and effectiveness of meta-analysis.
    Sochocky N; Milin R
    Curr Clin Pharmacol; 2013 Nov; 8(4):370-9. PubMed ID: 24050741
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized controlled trial investigating the safety and efficacy of aripiprazole in the long-term maintenance treatment of pediatric patients with irritability associated with autistic disorder.
    Findling RL; Mankoski R; Timko K; Lears K; McCartney T; McQuade RD; Eudicone JM; Amatniek J; Marcus RN; Sheehan JJ
    J Clin Psychiatry; 2014 Jan; 75(1):22-30. PubMed ID: 24502859
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aripiprazole and neuroleptic malignant syndrome.
    Chakraborty N; Johnston T
    Int Clin Psychopharmacol; 2004 Nov; 19(6):351-3. PubMed ID: 15486522
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tolerability and pharmacokinetics of aripiprazole in children and adolescents with psychiatric disorders: an open-label, dose-escalation study.
    Findling RL; Kauffman RE; Sallee FR; Carson WH; Nyilas M; Mallikaarjun S; Shoaf SE; Forbes RA; Boulton DW; Pikalov A
    J Clin Psychopharmacol; 2008 Aug; 28(4):441-6. PubMed ID: 18626272
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beneficial acute antidepressant effects of aripiprazole as an adjunctive treatment or monotherapy in bipolar patients unresponsive to mood stabilizers: results from a 16-week open-label trial.
    Mazza M; Squillacioti MR; Pecora RD; Janiri L; Bria P
    Expert Opin Pharmacother; 2008 Dec; 9(18):3145-9. PubMed ID: 19040335
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical effects and adverse reactions of off-label use of aripiprazole in children and adolescents with developmental disabilities.
    Valicenti-McDermott MR; Demb H
    J Child Adolesc Psychopharmacol; 2006 Oct; 16(5):549-60. PubMed ID: 17069544
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Open-label atomoxetine for attention-deficit/ hyperactivity disorder symptoms associated with high-functioning pervasive developmental disorders.
    Posey DJ; Wiegand RE; Wilkerson J; Maynard M; Stigler KA; McDougle CJ
    J Child Adolesc Psychopharmacol; 2006 Oct; 16(5):599-610. PubMed ID: 17069548
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Open-label aripiprazole in the treatment of acute bipolar depression: a prospective pilot trial.
    McElroy SL; Suppes T; Frye MA; Altshuler LL; Stanford K; Martens B; Leverich GS; Post RM; Keck PE
    J Affect Disord; 2007 Aug; 101(1-3):275-81. PubMed ID: 17229469
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aripiprazole: in the treatment of irritability associated with autistic disorder in pediatric patients.
    Curran MP
    Paediatr Drugs; 2011 Jun; 13(3):197-204. PubMed ID: 21500873
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ziprasidone and the corrected QT interval: a comprehensive summary of clinical data.
    Camm AJ; Karayal ON; Meltzer H; Kolluri S; O'Gorman C; Miceli J; Tensfeldt T; Kane JM
    CNS Drugs; 2012 Apr; 26(4):351-65. PubMed ID: 22452529
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aripiprazole improves social interaction in Taiwanese children with pervasive developmental disorder.
    Huang SC; Tsai SJ; Yang HJ
    Chang Gung Med J; 2010; 33(2):211-5. PubMed ID: 20438675
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aripiprazole: in adolescents with schizophrenia.
    Sanford M; Keating GM
    Paediatr Drugs; 2007; 9(6):419-23. PubMed ID: 18052412
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adjunctive low-dose aripiprazole with standard-dose sertraline in treating fresh major depressive disorder: a randomized, double-blind, controlled study.
    Lin CH; Lin SH; Jang FL
    J Clin Psychopharmacol; 2011 Oct; 31(5):563-8. PubMed ID: 21869699
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety and tolerability of once monthly aripiprazole treatment initiation in adults with schizophrenia stabilized on selected atypical oral antipsychotics other than aripiprazole.
    Potkin SG; Raoufinia A; Mallikaarjun S; Bricmont P; Peters-Strickland T; Kasper W; Baker RA; Eramo A; Sanchez R; McQuade R
    Curr Med Res Opin; 2013 Oct; 29(10):1241-51. PubMed ID: 23822566
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictors of aripiprazole treatment continuation in hospitalized patients.
    Coley KC; Fabian TJ; Kim E; Ammerman DK; Scipio TM; Saul MI; Kim MS; Whitehead R; Ganguli R
    J Clin Psychiatry; 2008 Sep; 69(9):1393-7. PubMed ID: 19012819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.